 | • レポートコード：MRC2-11QY04632 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は皮膚がん治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、凍結手術、免疫療法、光線力学療法、手術、その他の治療）市場規模、用途別（病院、診療所、がん研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別皮膚がん治療薬の競争状況、市場シェア ・世界の皮膚がん治療薬市場：種類別市場規模 2015年-2020年（化学療法、放射線療法、凍結手術、免疫療法、光線力学療法、手術、その他の治療） ・世界の皮膚がん治療薬市場：種類別市場規模予測 2021年-2026年（化学療法、放射線療法、凍結手術、免疫療法、光線力学療法、手術、その他の治療） ・世界の皮膚がん治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、がん研究センター、その他） ・世界の皮膚がん治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、がん研究センター、その他） ・北米の皮膚がん治療薬市場分析：米国、カナダ ・ヨーロッパの皮膚がん治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの皮膚がん治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の皮膚がん治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの皮膚がん治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Merck、Novartis、GlaxoSmithKline、Bristol Myers Squibb、Eli Lilly、Roche、Qiagen、Boehringer Ingelheim、Aqua Pharmaceuticals、Meda、Elekta AB、Varian Medical Systems、Bausch Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth.
In 2017, North America was the largest regional market, in terms of revenue.
Market Analysis and Insights: Global Skin Cancer Therapeutics Market
The global Skin Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Skin Cancer Therapeutics Scope and Market Size
Skin Cancer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Skin Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Merck
Novartis
GlaxoSmithKline
Bristol Myers Squibb
Eli Lilly
Roche
Qiagen
Boehringer Ingelheim
Aqua Pharmaceuticals
Meda
Elekta AB
Varian Medical Systems
Bausch Health
Market segment by Type, the product can be split into
Chemotherapy
Radiotherapy
Cryosurgery
Immune Therapy
Photodynamic Therapy
Surgery
Other Treatments
Market segment by Application, split into
Hospital
Clinic
Cancer Research Center
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Skin Cancer Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Skin Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Radiotherapy
1.4.4 Cryosurgery
1.4.5 Immune Therapy
1.4.6 Photodynamic Therapy
1.4.7 Surgery
1.4.8 Other Treatments
1.5 Market by Application
1.5.1 Global Skin Cancer Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Cancer Research Center
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Skin Cancer Therapeutics Market Perspective (2015-2026)
2.2 Global Skin Cancer Therapeutics Growth Trends by Regions
2.2.1 Skin Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Skin Cancer Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Skin Cancer Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Skin Cancer Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Skin Cancer Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Skin Cancer Therapeutics Players by Market Size
3.1.1 Global Top Skin Cancer Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Skin Cancer Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Skin Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Skin Cancer Therapeutics Market Concentration Ratio
3.2.1 Global Skin Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Skin Cancer Therapeutics Revenue in 2019
3.3 Skin Cancer Therapeutics Key Players Head office and Area Served
3.4 Key Players Skin Cancer Therapeutics Product Solution and Service
3.5 Date of Enter into Skin Cancer Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Skin Cancer Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Skin Cancer Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Skin Cancer Therapeutics Market Size by Application (2015-2020)
5.2 Global Skin Cancer Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Skin Cancer Therapeutics Market Size (2015-2020)
6.2 Skin Cancer Therapeutics Key Players in North America (2019-2020)
6.3 North America Skin Cancer Therapeutics Market Size by Type (2015-2020)
6.4 North America Skin Cancer Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Skin Cancer Therapeutics Market Size (2015-2020)
7.2 Skin Cancer Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Skin Cancer Therapeutics Market Size by Type (2015-2020)
7.4 Europe Skin Cancer Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Skin Cancer Therapeutics Market Size (2015-2020)
8.2 Skin Cancer Therapeutics Key Players in China (2019-2020)
8.3 China Skin Cancer Therapeutics Market Size by Type (2015-2020)
8.4 China Skin Cancer Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Skin Cancer Therapeutics Market Size (2015-2020)
9.2 Skin Cancer Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Skin Cancer Therapeutics Market Size by Type (2015-2020)
9.4 Japan Skin Cancer Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Skin Cancer Therapeutics Market Size (2015-2020)
10.2 Skin Cancer Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Skin Cancer Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Skin Cancer Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Skin Cancer Therapeutics Market Size (2015-2020)
11.2 Skin Cancer Therapeutics Key Players in India (2019-2020)
11.3 India Skin Cancer Therapeutics Market Size by Type (2015-2020)
11.4 India Skin Cancer Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Skin Cancer Therapeutics Market Size (2015-2020)
12.2 Skin Cancer Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Skin Cancer Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Skin Cancer Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Skin Cancer Therapeutics Introduction
13.1.4 Pfizer Revenue in Skin Cancer Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Skin Cancer Therapeutics Introduction
13.2.4 Merck Revenue in Skin Cancer Therapeutics Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Skin Cancer Therapeutics Introduction
13.3.4 Novartis Revenue in Skin Cancer Therapeutics Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Skin Cancer Therapeutics Introduction
13.4.4 GlaxoSmithKline Revenue in Skin Cancer Therapeutics Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Bristol Myers Squibb
13.5.1 Bristol Myers Squibb Company Details
13.5.2 Bristol Myers Squibb Business Overview
13.5.3 Bristol Myers Squibb Skin Cancer Therapeutics Introduction
13.5.4 Bristol Myers Squibb Revenue in Skin Cancer Therapeutics Business (2015-2020)
13.5.5 Bristol Myers Squibb Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Skin Cancer Therapeutics Introduction
13.6.4 Eli Lilly Revenue in Skin Cancer Therapeutics Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 Roche
13.7.1 Roche Company Details
13.7.2 Roche Business Overview
13.7.3 Roche Skin Cancer Therapeutics Introduction
13.7.4 Roche Revenue in Skin Cancer Therapeutics Business (2015-2020)
13.7.5 Roche Recent Development
13.8 Qiagen
13.8.1 Qiagen Company Details
13.8.2 Qiagen Business Overview
13.8.3 Qiagen Skin Cancer Therapeutics Introduction
13.8.4 Qiagen Revenue in Skin Cancer Therapeutics Business (2015-2020)
13.8.5 Qiagen Recent Development
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Details
13.9.2 Boehringer Ingelheim Business Overview
13.9.3 Boehringer Ingelheim Skin Cancer Therapeutics Introduction
13.9.4 Boehringer Ingelheim Revenue in Skin Cancer Therapeutics Business (2015-2020)
13.9.5 Boehringer Ingelheim Recent Development
13.10 Aqua Pharmaceuticals
13.10.1 Aqua Pharmaceuticals Company Details
13.10.2 Aqua Pharmaceuticals Business Overview
13.10.3 Aqua Pharmaceuticals Skin Cancer Therapeutics Introduction
13.10.4 Aqua Pharmaceuticals Revenue in Skin Cancer Therapeutics Business (2015-2020)
13.10.5 Aqua Pharmaceuticals Recent Development
13.11 Meda
10.11.1 Meda Company Details
10.11.2 Meda Business Overview
10.11.3 Meda Skin Cancer Therapeutics Introduction
10.11.4 Meda Revenue in Skin Cancer Therapeutics Business (2015-2020)
10.11.5 Meda Recent Development
13.12 Elekta AB
10.12.1 Elekta AB Company Details
10.12.2 Elekta AB Business Overview
10.12.3 Elekta AB Skin Cancer Therapeutics Introduction
10.12.4 Elekta AB Revenue in Skin Cancer Therapeutics Business (2015-2020)
10.12.5 Elekta AB Recent Development
13.13 Varian Medical Systems
10.13.1 Varian Medical Systems Company Details
10.13.2 Varian Medical Systems Business Overview
10.13.3 Varian Medical Systems Skin Cancer Therapeutics Introduction
10.13.4 Varian Medical Systems Revenue in Skin Cancer Therapeutics Business (2015-2020)
10.13.5 Varian Medical Systems Recent Development
13.14 Bausch Health
10.14.1 Bausch Health Company Details
10.14.2 Bausch Health Business Overview
10.14.3 Bausch Health Skin Cancer Therapeutics Introduction
10.14.4 Bausch Health Revenue in Skin Cancer Therapeutics Business (2015-2020)
10.14.5 Bausch Health Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Skin Cancer Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Skin Cancer Therapeutics Revenue
Table 3. Ranking of Global Top Skin Cancer Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Skin Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiotherapy
Table 7. Key Players of Cryosurgery
Table 8. Key Players of Immune Therapy
Table 9. Key Players of Photodynamic Therapy
Table 10. Key Players of Surgery
Table 11. Key Players of Other Treatments
Table 12. Global Skin Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Skin Cancer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Skin Cancer Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Skin Cancer Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Skin Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Skin Cancer Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Skin Cancer Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Skin Cancer Therapeutics Players
Table 23. Global Skin Cancer Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Skin Cancer Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Skin Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Therapeutics as of 2019)
Table 26. Global Skin Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Skin Cancer Therapeutics Product Solution and Service
Table 29. Date of Enter into Skin Cancer Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Skin Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Skin Cancer Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Skin Cancer Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Skin Cancer Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Skin Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Skin Cancer Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Skin Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Skin Cancer Therapeutics Market Share (2019-2020)
Table 39. North America Skin Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Skin Cancer Therapeutics Market Share by Type (2015-2020)
Table 41. North America Skin Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Skin Cancer Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Skin Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Skin Cancer Therapeutics Market Share (2019-2020)
Table 45. Europe Skin Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Skin Cancer Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Skin Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Skin Cancer Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Skin Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Skin Cancer Therapeutics Market Share (2019-2020)
Table 51. China Skin Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Skin Cancer Therapeutics Market Share by Type (2015-2020)
Table 53. China Skin Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Skin Cancer Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Skin Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Skin Cancer Therapeutics Market Share (2019-2020)
Table 57. Japan Skin Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Skin Cancer Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Skin Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Skin Cancer Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Skin Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Skin Cancer Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Skin Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Skin Cancer Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Skin Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Skin Cancer Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Skin Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Skin Cancer Therapeutics Market Share (2019-2020)
Table 69. India Skin Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Skin Cancer Therapeutics Market Share by Type (2015-2020)
Table 71. India Skin Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Skin Cancer Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Skin Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Skin Cancer Therapeutics Market Share (2019-2020)
Table 75. Central & South America Skin Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Skin Cancer Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Skin Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Skin Cancer Therapeutics Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Product
Table 87. Merck Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 88. Merck Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 93. Novartis Recent Development
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Product
Table 97. GlaxoSmithKline Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 98. GlaxoSmithKline Recent Development
Table 99. Bristol Myers Squibb Company Details
Table 100. Bristol Myers Squibb Business Overview
Table 101. Bristol Myers Squibb Product
Table 102. Bristol Myers Squibb Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 103. Bristol Myers Squibb Recent Development
Table 104. Eli Lilly Company Details
Table 105. Eli Lilly Business Overview
Table 106. Eli Lilly Product
Table 107. Eli Lilly Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 108. Eli Lilly Recent Development
Table 109. Roche Company Details
Table 110. Roche Business Overview
Table 111. Roche Product
Table 112. Roche Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 113. Roche Recent Development
Table 114. Qiagen Business Overview
Table 115. Qiagen Product
Table 116. Qiagen Company Details
Table 117. Qiagen Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 118. Qiagen Recent Development
Table 119. Boehringer Ingelheim Company Details
Table 120. Boehringer Ingelheim Business Overview
Table 121. Boehringer Ingelheim Product
Table 122. Boehringer Ingelheim Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 123. Boehringer Ingelheim Recent Development
Table 124. Aqua Pharmaceuticals Company Details
Table 125. Aqua Pharmaceuticals Business Overview
Table 126. Aqua Pharmaceuticals Product
Table 127. Aqua Pharmaceuticals Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 128. Aqua Pharmaceuticals Recent Development
Table 129. Meda Company Details
Table 130. Meda Business Overview
Table 131. Meda Product
Table 132. Meda Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 133. Meda Recent Development
Table 134. Elekta AB Company Details
Table 135. Elekta AB Business Overview
Table 136. Elekta AB Product
Table 137. Elekta AB Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 138. Elekta AB Recent Development
Table 139. Varian Medical Systems Company Details
Table 140. Varian Medical Systems Business Overview
Table 141. Varian Medical Systems Product
Table 142. Varian Medical Systems Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 143. Varian Medical Systems Recent Development
Table 144. Bausch Health Company Details
Table 145. Bausch Health Business Overview
Table 146. Bausch Health Product
Table 147. Bausch Health Revenue in Skin Cancer Therapeutics Business (2015-2020) (Million US$)
Table 148. Bausch Health Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Skin Cancer Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Cryosurgery Features
Figure 5. Immune Therapy Features
Figure 6. Photodynamic Therapy Features
Figure 7. Surgery Features
Figure 8. Other Treatments Features
Figure 9. Global Skin Cancer Therapeutics Market Share by Application: 2020 VS 2026
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Cancer Research Center Case Studies
Figure 13. Others Case Studies
Figure 14. Skin Cancer Therapeutics Report Years Considered
Figure 15. Global Skin Cancer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Skin Cancer Therapeutics Market Share by Regions: 2020 VS 2026
Figure 17. Global Skin Cancer Therapeutics Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Skin Cancer Therapeutics Market Share by Players in 2019
Figure 20. Global Top Skin Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Therapeutics as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Skin Cancer Therapeutics Revenue in 2019
Figure 22. North America Skin Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Skin Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Skin Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Skin Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Skin Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Skin Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Skin Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
皮膚がん診断・治療の世界市場（～2026年） Skin cancer is the uncontrolled development of anomalous skin cells. The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. Market Analysis and Insights: Global Skin Cancer Diagnosis and Therapeutics Market Th…- 非黒色腫皮膚がんの世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…
- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 非黒色腫皮膚がん治療の世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…